NSAID PUD
Intro:
25% of chronic NSAIDs users will develop ulcer, especially in the first 3 months
2 -4% will bleed of perforate
Therefore it is important to identify high risk patients and institute strategies to prevent ulcers
RF:
Age > 65 y.o. (OR 4.7)
Higher NSAID dose (OR 8)
H/O NSAID < 1 month (OR 7.2)
Concurrent steroid (OR 4.4)
Concurrent anticoagulants (OR 12.7)
Prior PUD (OR 2.29)
Prior GIB (OR 2.56)
ASA (RR 2-4)
H. pylori:
PUD risk with underlying H. pylori alone (increased by a factor of 1.79), NSAID (4.85), HP + NSAID (6.13)
PPI + ASA is better than HP eradication alone
After HP eradication, PPI + ASA is better than ASA alone
Prevention by Mucosal Protection:
Co-therapy with PPI addition
H2RA (Can prevent DU but NSAID GU not so well)
Synthetic PG E1 analog
Substitute with COX2 (reduce NSAID PUD but doesn’t prevent NSAID PUD, also has CV risk)
Doesn’t work: Sucralfate / Enteric coating NSAIDs
Risk Factors for NSAID GI toxicity:
High Risk:
H/O previously complicated ulcer,especially if recent
>2 RF
Moderate Risk:
Age > 65
High risk NSAID therapy
H/O previously uncomplicated ulcer
Concurrent use of ASA, steroids or anticoagulation
Low Risk:
No risk Factor
Note: H. pylori is an independent and additive risk factor and needs to be addressed.
Recommendation for prevention of NSAID related ulcer complications:
|
GI Risk: |
||
|
Low |
Mod |
High |
Low CV Risk |
NSAID alone |
NSAID + PPI / Misoprostol |
COX2 + PPI / Miso Alternative rx if possible |
High CV Risk (ASA) |
Naproxen + PPI / Misoprostol |
Naproxen + PPI / Misoprostol |
Avoid NSAIDs / COX2 Use Alternative rx |
edited 19th July 2010